Shares of Avadel Pharmaceuticals PLC (AVDL, Financial) fell 15.83% in mid-day trading on Nov 12. The stock reached an intraday low of $13.12, before recovering slightly to $13.72, down from its previous close of $16.30. This places AVDL 28.13% below its 52-week high of $19.09 and 33.85% above its 52-week low of $10.25. Trading volume was 1,551,375 shares, 168.1% of the average daily volume of 922,709.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 10 analysts, the average target price for Avadel Pharmaceuticals PLC (AVDL, Financial) is $24.70 with a high estimate of $30.00 and a low estimate of $20.00. The average target implies an upside of 80.03% from the current price of $13.72. More detailed estimate data can be found on the Avadel Pharmaceuticals PLC (AVDL) Forecast page.
Based on the consensus recommendation from 10 brokerage firms, Avadel Pharmaceuticals PLC's (AVDL, Financial) average brokerage recommendation is currently 1.6, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
